Clinical Trial Update: Angiotensin II Blockade and Inflammation in Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial update on angiotensin II blockade and inflammation in overweight and obese individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity
• Overweight
• Prehypertension

Snippet

Sponsor: Virginia Polytechnic Institute and State University | Conditions: Overweight, Obese | Phase 4 | Status: COMPLETED | Results posted: 2015-01-12